Dr. Ingrid A Mayer, MD
Claim this profileVanderbilt University/Ingram Cancer Center
Area of expertise
Breast Cancer
Ingrid A Mayer, MD has run 9 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Ingrid A Mayer, MD has run 5 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Vanderbilt University/Ingram Cancer Center
Vanderbilt University Medical Center
Clinical Trials Ingrid A Mayer, MD is currently running
Avelumab Combinations
for Triple Negative Breast Cancer
This phase II trial studies how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the combination of avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage IV or is not able to be removed by surgery (unresectable) and has come back (recurrent). Immunotherapy with checkpoint inhibitors like avelumab require activation of the patient's immune system. This trial includes a two week induction or lead-in of medications that can stimulate the immune system. It is our hope that this induction will improve the response to immunotherapy with avelumab. One treatment, sacituzumab Govitecan, is a monoclonal antibody called sacituzumab linked to a chemotherapy drug called SN-38. Sacituzumab govitecan is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of tumor cells, known as Tumor-associated calcium signal transducer 2 (TROP2) receptors, and delivers SN-38 to kill them. Another treatment, liposomal doxorubicin, is a form of the anticancer drug doxorubicin that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than doxorubicin, and may enhance factors associated with immune response. The third medication is called binimetinib, which may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth, and may help activate the immune system. It is not yet known whether giving avelumab in combination with liposomal doxorubicin with or without binimetinib, or the combination of avelumab with sacituzumab govitecan will work better in treating patients with triple negative breast cancer.
Recruiting
1 award
Phase 2
11 criteria
Personalized Adaptive Novel Agents
for Breast Cancer
This trial is testing new medicines along with regular cancer treatment to find the best combinations for breast cancer patients. It focuses on identifying which treatments work best based on specific cancer characteristics. Early signs of success are monitored using MRI scans and tests on blood and tissue samples.
Recruiting
1 award
Phase 2
16 criteria
More about Ingrid A Mayer, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Ingrid A Mayer, MD has experience with
- Palbociclib
- Sacituzumab Govitecan
- Avelumab
- BYL719
- Letrozole
- Ribociclib
Breakdown of trials Ingrid A Mayer, MD has run
Breast Cancer
Breast cancer
Cancer
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ingrid A Mayer, MD specialize in?
Ingrid A Mayer, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Ingrid A Mayer, MD currently recruiting for clinical trials?
Yes, Ingrid A Mayer, MD is currently recruiting for 2 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Ingrid A Mayer, MD has studied deeply?
Yes, Ingrid A Mayer, MD has studied treatments such as Palbociclib, Sacituzumab Govitecan, Avelumab.
What is the best way to schedule an appointment with Ingrid A Mayer, MD?
Apply for one of the trials that Ingrid A Mayer, MD is conducting.
What is the office address of Ingrid A Mayer, MD?
The office of Ingrid A Mayer, MD is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.